Urotoday International Journal
UIJ - A randomized double-blind phase 3 trial comparing docetaxel combined with dasatinib to docetaxel combined with placebo in castration-resistant prostate cancer – CA180-227
Your session will expire in 8 hours requiring you to log in each day to view content.
mobile news
Visit our mobile news channel today and get the latest Urological reviews, conference coverage, surgical techniques, clinical updates and more!